Complying with USP Chapters 41 and 1251 revisions for pharma quality control
Join this webinar to gain insight about the changes to United States Pharmacopeia (USP) General Chapters 41 and 1251 on balance requirements for quality control.
This webinar focuses on the recent revisions to United States Pharmacopeia (USP) General Chapters 41 and 1251, mandatory since 1 February 2026, and what it means for pharmaceutical quality professionals.
This session features an expert from METTLER TOLEDO with expertise in compliance with regulations when using weighing instruments. He will explain the updated requirements for balances relevant for QC, particularly the key revisions in USP General Chapters 41 and 1251.
Gain expert insight on:
- What’s new in USP 41? Calibration, measurement uncertainty, minimum weight and performance checks
- What’s new in USP 1251? Safety factor concept
- How to fulfil USP 41 and 1251 requirements.
At the end of the webinar our speaker will address specific USP-related questions in a Q&A format.
USP is the single reference work for the quality control of drugs in the United States (Pharma QC). It is therefore also binding for pharmaceutical companies in other regions of the world who export into the US market.
Key learning points:
- Introduction to USP – history and structure of compendium
- Overview on requirements for Balances
- Mandatory essentials of USP General Chapter 41 -calibration, minimum weight, repeatability and accuracy requirements, and performance checks
- Informational statements of USP General Chapter 1251 – the concept of a safety factor
- Performance checks – general requirements
SPEAKERS
Dr Klaus Fritsch – Manager Compliance at Laboratory Weighing, METTLER TOLEDO
As senior metrologist and regulatory expert, Klaus consults the industry to achieve compliance with regulations when using weighing instruments. Klaus is expert advisor for USP and Ph. Eur. and contributing author to calibration guidelines of EURAMET and ASTM.
FAQs
FAQs
Is the panel discussion free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the panel discussion take place?
4 March 2026 at 3PM GMT.
Can I watch it later?
The panel discussion will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the panel discussion be?
This panel discussion will last up to an hour.
What do I need to watch this panel discussion?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
